Mapping the future of advanced therapies

From ex vivo foundations to emerging in vivo frontiers

Advanced therapies are at an inflection point. Programs built on advanced ex vivo platforms are now intersecting with rapidly emerging in vivo approaches, driven by progress in targeted delivery, gene expression control, genome editing, and immunology.  

The Advanced Therapies Leadership & Acceleration Summit (ATLAS) will examine how innovation across ex vivo and in vivo strategies is redefining the relationship between biology and manufacturing. Bringing together senior scientific and strategy leaders, the summit will explore how scientific progress translates into CMC readiness, robust platforms, and scalable pathways from pre-clinical to commercial success.

Date